177 related articles for article (PubMed ID: 17899077)
1. Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma.
Thistlethwaite FC; Elkord E; Griffiths RW; Burt DJ; Shablak AM; Campbell JD; Gilham DE; Austin EB; Stern PL; Hawkins RE
Cancer Immunol Immunother; 2008 May; 57(5):623-34. PubMed ID: 17899077
[TBL] [Abstract][Full Text] [Related]
2. A phase I trial of CD3/CD28-activated T cells (Xcellerated T cells) and interleukin-2 in patients with metastatic renal cell carcinoma.
Thompson JA; Figlin RA; Sifri-Steele C; Berenson RJ; Frohlich MW
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3562-70. PubMed ID: 14506142
[TBL] [Abstract][Full Text] [Related]
3. Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples.
Powell DJ; Parker LL; Rosenberg SA
J Immunother; 2005; 28(4):403-11. PubMed ID: 16000960
[TBL] [Abstract][Full Text] [Related]
4. Effect of Peripheral Blood CD4 + CD25 + Regulatory T Cell on Postoperative Immunotherapy for Patients with Renal Carcinoma.
Zhang CH; Huang Y
Asian Pac J Cancer Prev; 2016; 17(4):2027-30. PubMed ID: 27221890
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor.
Montagna D; Turin I; Schiavo R; Montini E; Zaffaroni N; Villa R; Secondino S; Schiavetto I; Caliogna L; Locatelli F; Libri V; Pession A; Tonelli R; Maccario R; Siena S; Pedrazzoli P
Cytotherapy; 2012 Jan; 14(1):80-90. PubMed ID: 21942841
[TBL] [Abstract][Full Text] [Related]
6. Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study.
Kobayashi H; Tanaka Y; Yagi J; Osaka Y; Nakazawa H; Uchiyama T; Minato N; Toma H
Cancer Immunol Immunother; 2007 Apr; 56(4):469-76. PubMed ID: 16850345
[TBL] [Abstract][Full Text] [Related]
7. An innovative method to generate a Good Manufacturing Practice-ready regulatory T-cell product from non-mobilized leukapheresis donors.
Zhang W; Smythe J; Frith E; Belfield H; Clarke S; Watt SM; Danby R; Benjamin S; Peniket A; Roberts DJ
Cytotherapy; 2015 Sep; 17(9):1268-79. PubMed ID: 26276008
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma.
Kobayashi H; Tanaka Y; Yagi J; Minato N; Tanabe K
Cancer Immunol Immunother; 2011 Aug; 60(8):1075-84. PubMed ID: 21519826
[TBL] [Abstract][Full Text] [Related]
9. Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival.
Griffiths RW; Elkord E; Gilham DE; Ramani V; Clarke N; Stern PL; Hawkins RE
Cancer Immunol Immunother; 2007 Nov; 56(11):1743-53. PubMed ID: 17487490
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells.
Elkord E; Burt DJ; Drijfhout JW; Hawkins RE; Stern PL
Cancer Immunol Immunother; 2008 Jun; 57(6):833-47. PubMed ID: 18004564
[TBL] [Abstract][Full Text] [Related]
11. Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes.
Sloan AE; Dansey R; Zamorano L; Barger G; Hamm C; Diaz F; Baynes R; Wood G
Neurosurg Focus; 2000 Dec; 9(6):e9. PubMed ID: 16817692
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo activated memory T-lymphocytes as adoptive cellular therapy of human renal cell tumour targets with potentiation by cis-diamminedichloroplatinum(II).
Gold JE; Masters TR; Babbit B; Fine EM; Weber HN; Unger PD; Leventhal I; Zippe CD; Osband ME
Br J Urol; 1995 Jul; 76(1):115-22. PubMed ID: 7648042
[TBL] [Abstract][Full Text] [Related]
13. Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cells.
Meijer SL; Dols A; Urba WJ; Hu HM; Smith II JW; Vetto J; Wood W; Doran T; Chu Y; Sayaharuban P; Alvord WG; Fox BA
J Immunother; 2002; 25(4):359-72. PubMed ID: 12142559
[TBL] [Abstract][Full Text] [Related]
14. Autolymphocyte therapy for metastatic renal cell carcinoma: initial clinical results from 335 patients treated in a multisite clinical practice.
Lavin PT; Maar R; Franklin M; Ross S; Martin J; Osband ME
Transplant Proc; 1992 Dec; 24(6):3059-64. PubMed ID: 1466057
[No Abstract] [Full Text] [Related]
15. Phase II trial of autologous tumor vaccination, anti-CD3-activated vaccine-primed lymphocytes, and interleukin-2 in stage IV renal cell cancer.
Chang AE; Li Q; Jiang G; Sayre DM; Braun TM; Redman BG
J Clin Oncol; 2003 Mar; 21(5):884-90. PubMed ID: 12610189
[TBL] [Abstract][Full Text] [Related]
16. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
17. Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer.
Braun MW; Abdelhakim H; Li M; Hyter S; Pessetto Z; Koestler DC; Pathak HB; Dunavin N; Godwin AK
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33037114
[TBL] [Abstract][Full Text] [Related]
18. [Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+ CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma].
Liu CF; Guo Z; Si TG; Xing WG; Liu F; Xing JZ
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):902-5. PubMed ID: 20646510
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.
Xia G; He J; Leventhal JR
Am J Transplant; 2008 Feb; 8(2):298-306. PubMed ID: 18190656
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
